Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001096906-24-002004
Filing Date
2024-10-15
Accepted
2024-10-15 17:05:08
Documents
1
Period of Report
2024-01-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3414
  Complete submission text file 0001096906-24-002004.txt   4994
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Issuer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address
Valencia Catalina (Reporting) CIK: 0001944813 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54296 | Film No.: 241372565